Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company ...
Lung cancer rising among non-smokers — here's why
The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising ...
Merus N.V.: Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma
This marks the second BTD for petosemtamab in HNSCCUTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025(Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length mult ...
The Pharma Letter13h
Purple Biotech advances NT219 into Phase II head and neck cancer study
Israel-based clinical-stage company Purple Biotech today announced it is advancing into a Phase II study with NT219 in ...
Pharmabiz1d
Innovent receives second fast track designation from US FDA for IBI363 in squamous non-small cell lung cancer
San Francisco, US Tuesday, February 18, 2025, 09:00 Hrs [IST] ...
Purple Biotech advances NT219 into Phase 2 head, neck cancer trial
Purple Biotech (PPBT) is advancing into a Phase 2 study with NT219 in patients with recurrent/metastatic squamous cell carcinoma of the head ...
Medpage Today on MSN2d
Add-On Cemiplimab Shows Promise as First-Line Treatment for Penile Cancer
SAN FRANCISCO -- A combination of cemiplimab (Libtayo) and standard-of-care chemotherapy appeared to be effective in patients ...
Managed Healthcare Executive5d
Blood or Marrow Transplant Recipients Face Higher Skin Cancer Risk, Study Shows
Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...
Sporting News24d
Sean McDermott skin cancer, explained: How Bills coach beat squamous cell and basal cell carcinoma
The Sporting News details everything you need to know about McDermott's battle with skin cancer. McDermott first revealed in 2021 that he had squamous cell carcinoma "several times." He added ...
Medical Xpress26d
Study reveals novel insights into the molecular pathology of esophageal squamous cell carcinoma
More information: Bo Tian et al, Dysregulated inclusion of BOLA3 exon 3 promoted by HNRNPC accelerates the progression of esophageal squamous cell carcinoma, Frontiers of Medicine (2024). DOI: 10. ...